Lisanti Capital Growth LLC purchased a new position in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS – Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 169,410 shares of the company’s stock, valued at approximately $2,438,000. Lisanti Capital Growth LLC owned 0.11% of Integral Ad Science at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in IAS. Skandinaviska Enskilda Banken AB publ purchased a new stake in shares of Integral Ad Science during the third quarter valued at approximately $58,000. DekaBank Deutsche Girozentrale bought a new stake in Integral Ad Science during the 3rd quarter valued at $62,000. Amalgamated Bank lifted its holdings in Integral Ad Science by 19.9% during the 3rd quarter. Amalgamated Bank now owns 6,951 shares of the company’s stock worth $83,000 after purchasing an additional 1,156 shares in the last quarter. Sherbrooke Park Advisers LLC purchased a new position in Integral Ad Science during the 3rd quarter valued at about $140,000. Finally, L2 Asset Management LLC purchased a new stake in shares of Integral Ad Science in the third quarter worth about $142,000. 95.78% of the stock is owned by institutional investors and hedge funds.
Integral Ad Science Price Performance
Shares of IAS stock traded down $0.07 during trading hours on Tuesday, hitting $9.90. 1,332,278 shares of the company’s stock were exchanged, compared to its average volume of 1,711,581. The company has a quick ratio of 3.21, a current ratio of 3.21 and a debt-to-equity ratio of 0.17. The firm has a 50 day moving average of $9.85 and a two-hundred day moving average of $12.85. The firm has a market cap of $1.58 billion, a P/E ratio of 248.81, a P/E/G ratio of 1.72 and a beta of 1.58. Integral Ad Science Holding Corp. has a fifty-two week low of $8.92 and a fifty-two week high of $20.88.
Insider Transactions at Integral Ad Science
In other news, CAO Alexis Gil II sold 3,177 shares of Integral Ad Science stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $10.24, for a total value of $32,532.48. Following the completion of the transaction, the chief accounting officer now owns 120,195 shares in the company, valued at approximately $1,230,796.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Tania Secor sold 6,570 shares of the business’s stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of $9.71, for a total value of $63,794.70. Following the completion of the sale, the chief financial officer now directly owns 230,888 shares of the company’s stock, valued at $2,241,922.48. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CAO Alexis Gil II sold 3,177 shares of Integral Ad Science stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $10.24, for a total value of $32,532.48. Following the transaction, the chief accounting officer now directly owns 120,195 shares in the company, valued at approximately $1,230,796.80. The disclosure for this sale can be found here. In the last three months, insiders have sold 67,082 shares of company stock worth $669,508. 2.00% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on IAS shares. BMO Capital Markets cut their price target on shares of Integral Ad Science from $18.00 to $16.00 and set an “outperform” rating for the company in a research report on Wednesday, February 28th. Piper Sandler reduced their price target on Integral Ad Science from $20.00 to $18.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 28th. Oppenheimer cut their price target on Integral Ad Science from $25.00 to $20.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 28th. Truist Financial decreased their target price on shares of Integral Ad Science from $26.00 to $17.00 and set a “buy” rating for the company in a report on Wednesday, February 28th. Finally, Benchmark reissued a “hold” rating on shares of Integral Ad Science in a report on Tuesday. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $17.38.
Get Our Latest Analysis on IAS
Integral Ad Science Company Profile
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Featured Articles
- Five stocks we like better than Integral Ad Science
- Dividend Capture Strategy: What You Need to Know
- Garmin Navigates to New Highs Driven By Wearables Trend
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How Can Investors Benefit From After-Hours Trading
- AbbVie Tracking for New Highs in 2024
Want to see what other hedge funds are holding IAS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integral Ad Science Holding Corp. (NASDAQ:IAS – Free Report).
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.